美国乳腺外科医师学会与乳腺影像学会2025年良性乳腺纤维上皮性病变管理指南
美国乳腺外科医师学会(ASBrS)与乳腺影像学会(SBI)采用改良德尔菲共识法和公众评议制定良性纤维上皮性病变管理指南。指南就纤维腺瘤的切除指征、手术方式、影像随访及良性叶状肿瘤的完整切除与再切除指征达成强共识,并为临床争议提供处理意见。
要点
- 粗针活检证实的纤维腺瘤且影像-病理一致、无 atypia 者,仅在有症状、患者意愿、达到一定大小或临床检查显示实质性生长时需切除。
- 粗针活检证实的纤维腺瘤无需影像随访,可回归年龄相应筛查;良性叶状肿瘤切除后同样无需随访影像。
- 疑似或担忧叶状肿瘤的病变需手术切除活检并完整切除肿物;良性叶状肿瘤切缘阳性不要求再切除,但若肿物被横断或担忧残留可考虑切缘再切除。
核心结论
- ASBrS 与 SBI 基于证据、共识和专家意见制定了良性乳腺纤维上皮性病变管理指南,为争议性处理提供明确意见,建议所有接诊医生将其整合到治疗中。
研究设计与样本
- 指南由美国乳腺外科医师学会(ASBrS)与乳腺影像学会(SBI)采用改良德尔菲共识法和公众评议制定。
诊断标准与关键数值
- 粗针活检证实的纤维腺瘤且影像-病理一致、无 atypia 者,仅在出现症状、患者偏好、达到一定大小或临床检查显示随时间实质性生长时推荐切除(强共识)。
- 切除纤维腺瘤时推荐完整切除、不横断肿物,选择切口时应考虑美观、感觉和其他因素(强共识)。
- 粗针活检证实的纤维腺瘤无需影像随访,可回归年龄相应筛查。
- 许多良性叶状肿瘤(BPT)在粗针活检时表现为纤维上皮性病变,这些病变及任何疑似或担忧叶状肿瘤的病变需手术切除活检并完整切除肿物。
- 良性叶状肿瘤切缘阳性不要求再切除,但若肿物被横断或切除活检后担忧残留病变,可考虑切缘再切除;已切除的良性叶状肿瘤无需随访影像,可回归年龄相应筛查。
临床应用与阅片要点
- 粗针活检证实的纤维腺瘤且影像-病理一致、无 atypia 者,无需常规影像随访,可回归年龄相应筛查。
- 疑似或担忧叶状肿瘤的纤维上皮性病变需手术切除活检并完整切除肿物。
- 良性叶状肿瘤切缘阳性不要求再切除,但若肿物被横断或担忧残留可考虑切缘再切除。
- 切除纤维腺瘤时推荐完整切除、不横断肿物,切口选择应考虑美观、感觉等因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
IMPORTANCE: Many patients are diagnosed with benign breast lesions; however, evidence- and consensus-based guidelines for the management of benign breast disease (BBD) are limited.
OBSERVATIONS: The American Society of Breast Surgeons (ASBrS) and the Society of Breast Imaging (SBI) developed guidelines for the management of benign fibroepithelial lesions (FELs) using a modified Delphi consensus methodology and public comment. There was strong consensus that core biopsy-proven concordant fibroadenomas without atypia only require excision if they were symptomatic, patient preferred, attained a certain size, or demonstrated substantive growth over time on clinical examination. There was strong consensus that when removing a fibroadenoma, complete excision without transection of the mass is recommended and surgeons should consider aesthetics, sensation, and other factors when selecting incision placement. Patients with core biopsy-proven concordant fibroadenomas do not require imaging follow-up and may return to age-appropriate screening. Many benign phyllodes tumors (BPTs) present as an FEL on core biopsy, and these lesions along with any lesions with suspicion of or concern for phyllodes tumors (PTs) require surgical excisional biopsy with complete excision of the mass. Re-excision of a BPT is not required for patients with a positive margin for BPT, but a margin re-excision may be considered if the mass was transected or there is concern of residual disease after excisional biopsy. Patients with BPT who have undergone excision do not require follow-up imaging and may return to age-appropriate screening.
CONCLUSIONS AND RELEVANCE: Evidence-informed, consensus and expert opinion-based guidelines for the management of benign FELs of the breast were developed. These guidelines provide clarification on the controversial management of benign FELs of the breast. Any practicing clinicians who treat patients with benign FELs should integrate these guidelines into treatment of their patients.
引用
- Rosenberger LH, White RL, Tafra L, et al. American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions. JAMA Surg. 2025. PMID: 41123921. doi:10.1001/jamasurg.2025.4392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。